Triple

T32226680
Position Surface form Disambiguated ID Type / Status
Subject FOLFIRI regimen E823219 entity
Predicate indicationContext P23162 FINISHED
Object treatment of metastatic colorectal cancer with RAS wild-type tumors when combined with anti-EGFR therapy LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: treatment of metastatic colorectal cancer with RAS wild-type tumors when combined with anti-EGFR therapy | Statement: [FOLFIRI regimen, indicationContext, treatment of metastatic colorectal cancer with RAS wild-type tumors when combined with anti-EGFR therapy]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: indicationContext
Context triple: [FOLFIRI regimen, indicationContext, treatment of metastatic colorectal cancer with RAS wild-type tumors when combined with anti-EGFR therapy]
  • A. indicationRegion
    Indicates that something serves as a sign, marker, or signal specifically associated with a particular geographic or spatial region.
  • B. labelIndication
    Indicates that a label or designation is assigned to an entity to specify its indication, purpose, or intended use.
  • C. indicatedFor chosen
    Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
  • D. hasIndication
    Indicates that one entity (typically a product, treatment, or intervention) is intended, approved, or suitable for use in addressing, preventing, or managing a particular condition, purpose, or circumstance.
  • E. designationContext
    Indicates the situational or organizational setting within which a particular designation, title, or label is assigned to an entity.
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69f3490b4f948190b99e4f999f5be25f completed April 30, 2026, 12:20 p.m.
NER Named-entity recognition batch_69f6bbcbd31c8190a482a5fd5040410d completed May 3, 2026, 3:06 a.m.
PD Predicate disambiguation batch_69f6ba6cef208190bc5cd43d96127004 completed May 3, 2026, 3:01 a.m.
Created at: May 1, 2026, 12:38 a.m.